EPIVAC
Effectiveness of pneumococcal and influenza vaccines
The EPIVAC group was formed within the primary health services of Tarragona-Valls and comprises a multidisciplinary group of researchers and primary health care professionals. It is a wll consolidated group accredited by IDIAP Jordi Gol and by AGAUR (agency for the management of university and research grants of the Catalan Generalitat). Basically the group carries out population-based clinical an epidemiological research into infectious respiratory diseases which are preventable by vaccination.
The group participates in the following projects
|
PI: Villalobos Martínez, Felipe. Post-Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID -19) Vaccine. Funding: Fondazione Penta ONLUS. Duration: 2021 - 2024 |
|
PI: Vila Corcoles, Angel. Efectividad clínica e impacto de la vacunación antineumocócica conjugada (VNC13) y/o polisacárida (VNP23) en adultos con distintas condiciones de riesgo: estudio de cohortes de base poblacional post introducción de la vacunación infantil universal con VNC13. Funding: Instituto de Salud Carlos III. Duration: 2021 - 2023 |
|
PI: Aragón Pérez, María. vACCine covid-19 monitoring readinESS (ACCESS). Funding: UMC Utrecht (University Medical Center Utrecht). Duration: 2020 - 2022 |
|
PI: Gutiérrez Jiménez, Núria. Validació del VIG-EXPRESS com a eina de valoració multidimensional / geriàtrica ràpida. Funding: Departament de Salut. Duration: 2021 - 2021 |
|
PI: Vila Corcoles, Angel. Incidencia y caracterización de perfiles de bajo/alto riesgo de complicación en personas >60 años con COVID19.. Funding: Instituto de Salud Carlos III. Duration: 2020 - 2021 |
|
PI: Gens Barberà, Montserrat. Efectividad de la implementación de distintas herramientas de Seguridad del Paciente para definir un nuevo mapa de riesgo en Atención Primaria. Funding: Instituto de Salud Carlos III. Duration: 2018 - 2021 |
Group Publications
|
Vila-Corcoles A, Satue-Gracia E, Vila-Rovira A, de Diego-Cabanes C, Forcadell-Peris MJ, Hospital-Guardiola I, Ochoa-Gondar O, Basora-Gallisa J. COVID19-related and all-cause mortality risk among middle-aged and older adults across the first epidemic wave of SARS-COV-2 infection: a population-based cohort stuJune 2020.dy in Southern Catalonia, Spain, March-. BMC Public Health. 2021 10; 21(1):1795. doi:10.1186/s12889-021-11879-2. Epub 2021 Oct 06. pmc:PMC8493770. PMID:34615512. IF: 2,521. |
|
Vila-Corcoles A, Satue-Gracia E, Vila-Rovira A, de Diego-Cabanes C, Forcadell-Peris MJ, Ochoa-Gondar O. Development of a predictive prognostic rule for early assessment of COVID-19 patients in primary care settings. Aten Primaria. 2021 11; 53(9):102118. doi:10.1016/j.aprim.2021.102118. Epub 2021 May 28. pmc:PMC8162822. PMID:34139400. IF: 1,137. |
|
Vila-Córcoles Á, Vila-Rovira Á, Satué-Gracia EM, Ochoa-Gondar O, de Diego-Cabanes C, Hospital-Guardiola I, Forcadell-Peris MJ, Martín-Luján F, Basora-Gallisà J. [Treatment setting, symptomatology, clinical course, severity degree and case-fatality rate in 536 adults over 50 years with laboratory-confirmed COVID-19 in Tarragona, Spain, March-June 2020.]. Rev Esp Salud Publica. 2021 Sep; 95. Epub 2021 Sep 08. Spanish. PMID:34493700. IF: 0,756. |
The group participates in the following publications
|
Azeli Y, Bardají A, Barbería E, Lopez-Madrid V, Bladé-Creixenti J, Fernández-Sender L, Bonet G, Rica E, Álvarez S, Fernández A, Axelsson C, Jiménez-Herrera MF. Clinical outcomes and safety of passive leg raising in out-of-hospital cardiac arrest: a randomized controlled trial. Crit Care. 2021 05; 25(1):176. doi:10.1186/s13054-021-03593-7. Epub 2021 May 25. pmc:PMC8152146. PMID:34034775. IF: 9,097. |
|
Gens-Barberà M, Hernández-Vidal N, Castro-Muniain C, Hospital-Guardiola I, Oya-Girona EM, Bejarano-Romero F, Rey-Reñones C, Martín-Luján F; en nombre del grupo de estudio de Calidad y Seguridad del Paciente de Tarragona (QiSP-TAR). [Patient safety incidents reported before and after the start of the COVID-19 pandemic in Primary Care in Tarragona]. Aten Primaria. 2021 Dec; 53 Suppl 1:102217. doi:10.1016/j.aprim.2021.102217. Spanish. pmc:PMC8708815. PMID:34961580. IF: 1,137. |
|
Gens-Barberà M, Hernández-Vidal N, Vidal-Esteve E, Mengíbar-García Y, Hospital-Guardiola I, Oya-Girona EM, Bejarano-Romero F, Castro-Muniain C, Satué-Gracia EM, Rey-Reñones C, Martín-Luján FM. Analysis of Patient Safety Incidents in Primary Care Reported in an Electronic Registry Application. Int J Environ Res Public Health. 2021 08; 18(17). doi:10.3390/ijerph18178941. Epub 2021 Aug 25. pmc:PMC8430626. PMID:34501530. IF: 2,849. |
|
Gens-Barberà M, Rey-Reñones C, Hernández-Vidal N, Vidal-Esteve E, Mengíbar-García Y, Hospital-Guardiola I, Palacios-Llamazares L, Satué-Gracia EM, Oya-Girona EM, Bejarano-Romero F, Astier-Peña MP, Martín-Luján F. Effectiveness of New Tools to Define an Up-to-Date Patient Safety Risk Map: A Primary Care Study Protocol. Int J Environ Res Public Health. 2021 08; 18(16). doi:10.3390/ijerph18168612. Epub 2021 Aug 15. pmc:PMC8392165. PMID:34444360. IF: 2,849. |
Indicators
|
Indicator |
2021 |
|---|---|
|
Researchers with PhD |
19 |
|
Total number of projects in which group members have participated |
6 |
|
Total number of projects in which the PI of the project has belonged to the group |
2 |
|
Total Funding |
414.486 € |
|
Scientific publications in indexed journals |
7 |
|
Total Impact factor |
20,35 |
|
Nº of articles in Q1 journals |
1 |
|
Q1 IF |
9,097 |
|
Nº of articles in Q2 journals |
0 |
|
Q2 IF |
